Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer

Kaban, Kuebra; Hinterleitner, Clemens; Zhou, Yanjun; Salva, Emine; Kantarci, Ayse Gulten; Salih, Helmut R.; Maerklin, Melanie

dc.contributor.author	Kaban, Kübra
dc.contributor.author	Hinterleitner, Clemens
dc.contributor.author	Zhou, Yanjun
dc.contributor.author	Salih, Helmut R.
dc.contributor.author	Märklin, Melanie
dc.date.accessioned	2021-12-20T11:35:37Z
dc.date.available	2021-12-20T11:35:37Z
dc.date.issued	2021
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/121891
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers13102397	de_DE
dc.subject.ddc	610	de_DE
dc.title	Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210824232002_01379
utue.personen.roh	Kaban, Kuebra
utue.personen.roh	Hinterleitner, Clemens
utue.personen.roh	Zhou, Yanjun
utue.personen.roh	Salva, Emine
utue.personen.roh	Kantarci, Ayse Gulten
utue.personen.roh	Salih, Helmut R.
utue.personen.roh	Maerklin, Melanie
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 2397	de_DE
dcterms.isPartOf.ZS-Volume	13 (10)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE